Blood Flow Restriction Training (BFR) in an Adolescent Population

February 6, 2024 updated by: Adam Weaver, Connecticut Children's Medical Center

A Determination of Efficacy and Therapeutic Benefits of Blood Flow Restriction Training in an Adolescent Population

While there are a number studies that have reported on the use of BFR in the adult population, there is limited information about the use of BFR in the adolescent population. This study aims to evaluate the use of BFR training in conjunction with traditional ACL (anterior cruciate ligament) reconstruction rehabilitation in adolescents.

The purpose of this study is to evaluate the addition of BFR-based exercise to traditional methods of physical therapy. Does the use of BFR-based exercise improve strength, hypertrophy, functional and patient reported outcomes after ACL Reconstruction in the adolescent population?

Study Overview

Detailed Description

The planned pilot study is a prospective case control study utilizing retrospective controls. The investigators will compare the use of exercises augmented with BFR with quantitative measurements of strength and patient reported outcomes. A total of 20 youth and adolescent patients undergoing a surgical procedure for ACL reconstruction at Connecticut Children's Elite Sports Medicine and completing physical therapy at Connecticut Children's Sports Physical Therapy will be recruited for this study. A review of data from 20 previous patients, matched for age, sex, BMI and surgical procedure that completed physical therapy at Connecticut Children's Sports Physical Therapy will be used as a comparison.

As part of this pilot study, the investigators will additionally collect prospective controls. This population will be patients not participating in physical therapy at Connecticut Children's, but underwent ACL reconstruction by Elite Sports Medicine. The investigators are unsure of the ability for us to collect prospective controls in a timely manner, hence the investigators will use the above described retrospective cohort as controls if the prospective controls prove difficult to recruit.

Identification and Recruitment:

All potential patients undergoing ACL reconstruction at Elite Sports Medicine will be approached for participation for this study. Eligible patients will be identified at their initial pre-operative appointment with the Sports Medicine Physician, Athletic Trainer, and Sports Physical Therapy Physical Therapist. Subject selection will be completed by those patients meeting the above outlined inclusion and exclusion criteria. At this time, the study purpose and protocol will be explained and a brief summary of the study will be provided.

Consent: Consent will take place at the pre-operative visit. The patient/parent will be given a detailed description of the purpose and methodology for this study. The participants will have the opportunity to read the consent forms and ask any questions they may have about the research. If the patients agree to participate, they will be asked to sign the consent form and a copy will be provided.

Retention: Eligible patients will be required to be seen for a minimum of 90% of patient visits to be included in this study.

In addition to the standard ACL protocol, patients in this study will utilize the Owen Recovery Science exercise protocol for BFR [18]. The following guidelines will be followed concerning exercise progression, occlusion pressure and difficulties with volume achievement. To determine the appropriate resistance for each exercise, the patient's 1 repetition maximum (1RM) will be attained using a repetition test [19]. This test will use a previously validated algorithm to determine the 1RM based on the weight used to perform a 7-10 repetition test [20]. Patient will perform the exercise with a weight they can comfortably lift for several repetitions. Based on the weight or resistance used, and the patient's perceived exertion a 1RM will be estimated using the modified OMNI-RES (OMNI perceived exertion scale for resistance). The starting load for each exercise will be 20-30% of their 1RM , or bodyweight resistance will be used when loading is not feasible.

Proposed Protocol Phase 1- Weeks 1 to 2

  • Quad Set: 10 second on, 10 second rest at 100% occlusion x10'

    o progress to isometrics at the edge of the table 60 degrees as clinically appropriate

  • Side Lying Hip Abduction, 30/15/15/15, at 80% occlusion
  • Hip Extension from prone 30/15/15/15, at 80% occlusion
  • Re-check load at the start of each Phase, to determine 1 RM (7-10 RM (repetition maximum) test on leg press)
  • Total BFR time approximately 24 minutes per session, with 2 sessions per week

Phase 2- Weeks 3 to 4

  • Replace Quad Set with Long Arc Quad (90-30deg), 30/15/15/15 at 80% occlusion
  • Replace Hip Extension with Leg Press (shuttle), 30/15/15/15 at 80% occlusion
  • Hip Abduction, 30/15/15/15 at 80% occlusion
  • Total BFR time approximately 24 minutes per session with 2 sessions per week

Phase 3- Weeks 5 to 6

  • Long Arc Quad (90-30deg), 30/15/15/15 at 80% occlusion
  • Leg Press (shuttle), 30/15/15/15 at 80% occlusion
  • Replace Hip Abduction with Bilateral Hip Bridge, 30/15/15/15 at 80% occlusion
  • Total BFR time approximately 24 minutes per session, with 2 sessions per week

Phase 4- Weeks 7 to 8

  • Leg Press (shuttle), 30/15/15/15 at 80% occlusion
  • Replace Long Arc Quad with Step Up 30/15/15/15 at 80% occlusion
  • Bilateral Hip Bridge, 30/15/15/15 at 80% occlusion
  • Total BFR time approximately 24 minutes per session, with 2 sessions per week

Phase 5- Weeks 9 to 12

  • Replace Bilateral Hip Bridge with Medial Step Down, 30/15/15/15 at 80% occlusion
  • Replace Step up with Split Squat, 30/15/15/15 at 80% occlusion
  • Leg Press (shuttle), 30/15/15/15 at 80% occlusion
  • Total BFR time approximately 24 minutes per session, with 2 sessions per week

Phase 6- Weeks 11 to 12

  • Progressively load exercises from phase 5
  • Total BFR time approximately 24 minutes per session, with 2 sessions per week

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • Farmington, Connecticut, United States, 06032
        • Connecticut Children's Sports Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients between the age of 12 and 18 years at the time of surgery.
  • Post-primary ACL reconstruction
  • Orthopaedic surgical intervention (including all additional procedures at the knee) completed by one of the Elite Sports Medicine physicians.
  • Patient completed postoperative rehabilitation following standard protocols
  • No contraindications to performing BFR, as outlined in the Owens Recovery[18] Science 2018 Personal Blood Flow Restriction manual.

Exclusion Criteria:

  • Patients older than 18 and younger than 12 at the time of surgery
  • Any additional diagnoses or deformity not related to knee injury that could affect knee strength
  • Additional lower extremity injury at time of knee injury (e.g., ankle injury) requiring treatment
  • Previous surgical intervention on the knee (ipsilateral and contralateral)
  • Patients with weight bearing restrictions for greater than two weeks after surgery due to concomitant pathology such as meniscal root/radial repair, chondral pathology, or multi-ligament pathology. . Generic exclusion: "Subjects not meeting all inclusion criteria."

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BFR Exercise Group

In addition to the standard ACL protocol, patients in this study will utilize the Owen Recovery Science exercise protocol for BFR [18]. The following guidelines will be followed concerning exercise progression, occlusion pressure and difficulties with volume achievement.

A total of 20 youth and adolescent patients undergoing a surgical procedure for ACL reconstruction at Connecticut Children's Elite Sports Medicine and completing physical therapy at Connecticut Children's Sports Physical Therapy will be recruited for this study.

The Delfi Tourniquet System is designed to be used in conjunction with exercise. The system automatically determines the degree of occlusion and allows for safe regulation of pressure. Patients will then complete exercises with the use of this device following the Owens Recovery Science Protocol
Other Names:
  • FDA Establishment Registration Number 9681444. Device Listing Number E127474. Classification Number 878.5910. Product Code KCY. 510(k) Exempt. MID: XCDELMED1099VAN
No Intervention: Non-BFR exercise group
As part of this pilot study, the investigators will additionally collect prospective controls. This population will be patients not participating in physical therapy at Connecticut Children's but underwent ACL reconstruction by Elite Sports Medicine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Isometric Quad strength Peak Torque
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric strength testing to measure peak torque quadriceps strength (unit: ft-lbs) as reported by isokinetic dynamometer on involved and uninvolved limb.
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric Quad Strength limb symmetry index
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Quadriceps limb symmetry index is calculated by taking the values from outcome 1. [ ( peak torque quadriceps involved limb (ft/lbs)/ peak torque quadriceps uninvolved limb (ft-lbs))*100] as reported by isokinetic dynamometer. This value is expressed as a percentage. 100% would equal perfect symmetry.
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric hamstring Strength Peak Torque
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric strength testing to measure peak torque hamstsring strength (unit: ft-lbs) as reported by isokinetic dynamometer on involved and uninvolved limb.
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric Hamstring Strength Limb Symmetry Index
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Hamstring limb symmetry index is calculated by taking the values from outcome 3 [ ( peak torque hamstring involved limb (ft/lbs) / peak torque hamstring uninvolved limb (ft-lbs))*100] as reported by isokinetic dynamometer. This value is expressed as a percentage.100% would equal perfect symmetry.
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric Hip Extension Strength Peak Torque
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric strength testing to measure peak torque hip extension in foot pounds as reported by isokinetic dynamometer
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Isometric hip extension Strength Limb Symmetry Index
Time Frame: Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Hip Extension limb symmetry index is calculated by taking the values from outcome 5 [ ( peak torque hip extension involved limb peak torque (ft/lbs) /hip extension uninvolved limb peak torque (ft-lbs))*100] as reported by isokinetic dynamometer. This value is expressed as a percentage.100% would equal perfect symmetry.
Change in strength at Pre-op, 3months post-op, 6-9 months post-op
Anterior step down test
Time Frame: Change in strength from 3months post-op, 6-9 months post-op
Anterior step down test measured in number of repetitions comparing involved to uninvolved lower extremity
Change in strength from 3months post-op, 6-9 months post-op
Y balance test
Time Frame: Change in strength from 3months post-op, 6-9 months post-op
Y balance test measuring distance of excursion in cm compared comparing involved to uninvolved lower extremity
Change in strength from 3months post-op, 6-9 months post-op
Lower Extremity Strength
Time Frame: Change in strength from 3months post-op, 6-9 months post-op
Single leg Bridge test measured in number of repetitions side to side
Change in strength from 3months post-op, 6-9 months post-op
Single Leg Hop Test Distance
Time Frame: 6-9 months post-op
Single Leg Hop Test measured in cm for involved and uninvolved limb.
6-9 months post-op
Single Leg Hop Test Distance Symmetry
Time Frame: 6-9 months post-op
Single Leg Hop Test measured in cm for involved and uninvolved limbs. Limb symmetry index is calculated by using the distance for involved and uninvolved [ ( involved limb distance / uninvolved limb distance)*100]. this value is expressed as a percentage. 100% would equal perfect symmetry.
6-9 months post-op
6 meter timed single leg hop
Time Frame: 6-9 months post-op
Timed 6 meter single leg hop for involved and uninvolved limb measured in seconds.
6-9 months post-op
6meter timed hop symmetry
Time Frame: 6-9 months post-op
Timed 6m single leg hop calculating limb symmetry index [ ( involved limb single leg hop time/ uninvolved single leg hop time)*100]. This value is expressed as a percentage. 100% would equal perfect symmetry.
6-9 months post-op
Single Leg Triple hop for distance
Time Frame: 6-9 months post-op
Triple Hop Test measured in cm for involved and uninvolved limb,
6-9 months post-op
Single Leg Triple Hop Symmetry
Time Frame: 6-9 months post-op
Single Leg Triple hop calculating limb symmetry index [ ( involved limb triple hop distance/ uninvolved triple hop distance)*100]. This value is expressed as a percentage. 100% would equal perfect symmetry.
6-9 months post-op
Single Leg Crossover hop for distance
Time Frame: 6-9 months post-op
Single leg Crossover hop Test measured in cm for involved and uninvolved limb.
6-9 months post-op
Single Leg Crossover Hop Symmetry
Time Frame: 6-9 months post-op
Single Leg Crossover Hop calculating limb symmetry index [ ( involved limb crossover hop distance/ crossover triple hop distance)*100]. This value is expressed as a percentage. 100% would equal perfect symmetry.
6-9 months post-op

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quad Hypertrophy
Time Frame: Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Thigh Circumference measured at location 10cm superior to patella and measured in cm comparing involved to uninvolved lower extremity
Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Pedi-IKDC (International Knee Documentation Committee)
Time Frame: And tracking change at Pre-op, 3months post-op, 6-9 months post-op
Patient Reported Outcome Measure- Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).
And tracking change at Pre-op, 3months post-op, 6-9 months post-op
KOOS (Knee Outcomes and Osteoarthritis Scale)
Time Frame: Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Patient Reported Outcome Measure- The score is a percentage score from 0 to 100, with 0 representing extreme problems and 100 representing no problems. This scoring direction, 100 indicating no problems
Tracking change at Pre-op, 3months post-op, 6-9 months post-op
ACL- RSI (Anterior Cruciate Ligament- Return to Sport after Injury)
Time Frame: Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Patient Reported Outcome Measure- ACL-RSI scores range from 0 to 100, with higher scores representing patients who are more ready to return to sport
Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Marx Activity Rating Scale
Time Frame: Tracking change at Pre-op, 3months post-op, 6-9 months post-op
Patient Reported Outcome Measure- This determines a patient's activity level as it pertains to running, cutting, deceleration and pivoting. A higher score indicates a higher activity level (0-16 max)
Tracking change at Pre-op, 3months post-op, 6-9 months post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adam Weaver, PT, DPT, Physical Therapist

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2020

Primary Completion (Actual)

January 15, 2023

Study Completion (Actual)

October 16, 2023

Study Registration Dates

First Submitted

February 20, 2020

First Submitted That Met QC Criteria

February 24, 2020

First Posted (Actual)

February 26, 2020

Study Record Updates

Last Update Posted (Actual)

February 7, 2024

Last Update Submitted That Met QC Criteria

February 6, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 19-168

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ACL Injury

Clinical Trials on Blood Flow Restriction using Delfi Personalized Tourniquet System

3
Subscribe